Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CAZZOLA, Mario")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 149

  • Page / 6
Export

Selection :

  • and

Recombinant human erythropoietin in the prevention and treatment of anemiaassociated with malignancyCAZZOLA, Mario.Medical oncology (Northwood). 1998, Vol 15, issn 1357-0560, 52 p., SUP1Serial Issue

Alternatives to conventional or myeloablative chemotherapy in myelodysplastic syndromeCAZZOLA, Mario.International journal of hematology. 2000, Vol 72, Num 2, pp 134-138, issn 0925-5710Article

Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary diseasePAGE, Clive; CAZZOLA, Mario.The European respiratory journal. 2014, Vol 44, Num 2, pp 475-482, issn 0903-1936, 8 p.Article

The relevance of transfusion-dependency in the prognostic assessment of patients with myeloid neoplasmsMALCOVATI, Luca; CAZZOLA, Mario.American journal of hematology. 2011, Vol 86, Num 3, pp 241-243, issn 0361-8609, 3 p.Article

The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD : A pilot studyCAZZOLA, Mario; MATERA, Maria Gabriella.Respiratory medicine. 2007, Vol 101, Num 5, pp 957-962, issn 0954-6111, 6 p.Article

Ultra-long-acting β2-adrenoceptor agonists : An emerging therapeutic option for asthma and COPD?MATERA, Maria Gabriella; CAZZOLA, Mario.Drugs (Basel). 2007, Vol 67, Num 4, pp 503-515, issn 0012-6667, 13 p.Article

Quality of life in clinical trials : assessment and utility with special reference to rHuEPOBRANDBERG, Y.Medical oncology (Northwood). 1998, Vol 15, pp S8-S12, issn 1357-0560, SUP1Article

Combination of Formoterol and Tiotropium in the Treatment of COPD: Effects on Lung FunctionCAZZOLA, Mario; TASHKIN, Donald P.COPD (Monticello (Sullivan County, N.Y.)). 2009, Vol 6, Num 5, pp 404-415, issn 1541-2555, 12 p.Article

Inhaled combination therapy with long-acting β2-Agonists and corticosteroids in stable COPDCAZZOLA, Mario; DAHL, Ronald.Chest. 2004, Vol 126, Num 1, pp 220-237, issn 0012-3692, 18 p.Article

Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancerBEGUIN, Y.Medical oncology (Northwood). 1998, Vol 15, pp S38-S46, issn 1357-0560, SUP1Article

Impact of anemia and fatigue on quality of life in cancer patients : a brief reviewTHOMAS, M. L.Medical oncology (Northwood). 1998, Vol 15, pp S3-S7, issn 1357-0560, SUP1Article

Myelodysplastic syndromes. Coping with ineffective hematopoiesisCAZZOLA, Mario; MALCOVATI, Luca.The New England journal of medicine. 2005, Vol 352, Num 6, pp 536-538, issn 0028-4793, 3 p.Article

Novel approaches to the treatment of bacterial lower respiratory tract infections: IntroductionCAZZOLA, Mario; SALTINI, Cesare.Respiration (Basel). 2005, Vol 72, Num 1, pp 7-8, issn 0025-7931, 2 p.Article

Anemia and quality of life in cancer patients : impact of transfusion and erythropoietinTHOMAS, M. L.Medical oncology (Northwood). 1998, Vol 15, pp S13-S18, issn 1357-0560, SUP1Article

Treatment of anaemia with rHuEpo in patients with MDSCASADEVALL, N.Medical oncology (Northwood). 1998, Vol 15, pp S35-S37, issn 1357-0560, SUP1Article

Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumoursNOWROUSIAN, M. R.Medical oncology (Northwood). 1998, Vol 15, pp S19-S28, issn 1357-0560, SUP1Article

Recombinant human erythropoietin (rHuEPO) therapy in patients with cancer-related anaemia : what have we learned?ÖSTERBORG, A.Medical oncology (Northwood). 1998, Vol 15, pp S47-S49, issn 1357-0560, SUP1Article

Aclidinium bromide for the treatment of chronic obstructive pulmonary diseaseCAZZOLA, Mario; PAGE, Clive P; GABRIELLA MATERA, Maria et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 9, pp 1205-1214, issn 1465-6566, 10 p.Article

Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPDANDO, Filippo; RUGGERI, Paolo; GIRBINO, Giuseppe et al.Respiratory medicine. 2008, Vol 102, Num 6, pp 815-818, issn 0954-6111, 4 p.Article

Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary diseaseMATERA, Maria Gabriella; ROGLIANI, Paola; CAZZOLA, Mario et al.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 7, pp 961-977, issn 1465-6566, 17 p.Article

Inhaled β2-adrenoceptor agonists : Cardiovascular safety in patients with obstructive lung diseaseCAZZOLA, Mario; MATERA, Maria G; DONNER, Claudio F et al.Drugs (Basel). 2005, Vol 65, Num 12, pp 1595-1610, issn 0012-6667, 16 p.Article

Clinical pharmacokinetics of salmeterolCAZZOLA, Mario; TESTI, Renato; MATERA, Maria Gabriella et al.Clinical pharmacokinetics. 2002, Vol 41, Num 1, pp 19-30, issn 0312-5963Article

Primary care of the patient with chronic obstructive pulmonary disease in ItalyCAZZOLA, Mario; BETTONCELLI, Germano; SESSA, Emiliano et al.Respiratory medicine. 2009, Vol 103, Num 4, pp 582-588, issn 0954-6111, 7 p.Article

Bacterial extracts for the prevention of acute exacerbations in chronic obstructive pulmonary disease : A point of viewCAZZOLA, Mario; ROGLIANI, Paola; CURRADI, Giacomo et al.Respiratory medicine. 2008, Vol 102, Num 3, pp 321-327, issn 0954-6111, 7 p.Article

Prognostic Classification and Risk Assessment in Myelodysplastic SyndromesCAZZOLA, Mario; MALCOVATI, Luca.Hematology/oncology clinics of North America. 2010, Vol 24, Num 2, issn 0889-8588, x, 459-468 [11 p.]Article

  • Page / 6